Esophageal Squamous Cell Carcinoma

• CLINICAL_TRIALS withdrawal · 2026-03-18
  Clinical Trial Update: Study of the Interest of Pursuing or Not the Chemotherapy for Patients With Metastatic Esophageal Cancer [Phase 2]

  A Phase 2 trial evaluating whether to pursue chemotherapy for metastatic esophageal squamous cell carcinoma was terminated.

• CLINICAL_TRIALS withdrawal · 2026-02-17
  Clinical Trial Update: S095033 in Combination With Paclitaxel as 2nd- or 3rd-line Treatment in Participants With Advanced or Metastatic ESCC [Phase 1, Phase 2]

  This clinical trial update indicates that the phase 1/2 study of S095033 in combination with paclitaxel for advanced or metastatic esophagea…

• CLINICAL_TRIALS withdrawal · 2025-08-26
  Clinical Trial Update: Adebrelimab Combined With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (ESCC) [NA]

  A clinical trial evaluating adebrelimab in combination with chemoradiotherapy for locally advanced unresectable esophageal squamous cell car…

• CLINICAL_TRIALS withdrawal · 2025-02-06
  Clinical Trial Update: Molecular Analysis of Gastric and OEsophageal Cancers STudy

  A molecular analysis study of gastric and esophageal cancers has been withdrawn from clinical trials.

• CLINICAL_TRIALS withdrawal · 2024-02-13
  Clinical Trial Update: Nutritional Supplementation in Reducing Complications in Patients With Locally Advanced Esophageal Cancer Undergoing Chemotherapy, Radiation Therapy, and/or Surgery [Phase 3]

  A Phase 3 trial evaluating nutritional supplementation to reduce complications in locally advanced esophageal cancer undergoing chemo/radiat…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS withdrawal · 2021-03-18
  Clinical Trial Update: Neoadjuvant Treatment of Nimotuzumab With Chemotherapy or Radiotherapy in Resectable Esophageal Squamous Cell Carcinoma [Phase 2, Phase 3]

  A neoadjuvant Nimotuzumab trial in resectable esophageal squamous cell carcinoma was withdrawn (Phase 2/Phase 3).

• CLINICAL_TRIALS withdrawal · 2015-03-05
  Clinical Trial Update: Neoadjuvant Chemotherapy of Nimotuzumab Plus Nab-Paclitaxel in Squamous Cell Carcinoma of Esophagus [Phase 2]

  Phase 2 neoadjuvant trial of nimotuzumab plus nab-paclitaxel for esophageal squamous cell carcinoma has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2015-03-05
  Clinical Trial Update: Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Squamous Cell Carcinoma of Esophagus [Phase 2]

  A Phase 2 trial of nanoparticle albumin-bound paclitaxel as neoadjuvant chemotherapy for esophageal squamous cell carcinoma has been withdra…

• CLINICAL_TRIALS withdrawal · 2015-03-05
  Clinical Trial Update: Nimotuzumab Plus Nab-paclitaxel and Cisplatin in Treating Patients With Advanced Esophageal Carcinoma [Phase 2]

  This trial update notes that a Phase 2 study of nimotuzumab plus nab-paclitaxel and cisplatin for advanced esophageal squamous cell carcinom…

• CLINICAL_TRIALS withdrawal · 2015-02-12
  Clinical Trial Update: Phase II Study of Maintenance Treatment of Nimotuzumab for Advanced Esophageal Carcinoma [Phase 2]

  Phase II trial of maintenance nimotuzumab for advanced esophageal squamous cell carcinoma has been withdrawn.